Dr. Christopher "Topper" Doehring, vice president of medical affairs for Franciscan St. Francis , explains how our hospitals took immediate measures to stave off potential concerns related to the controversial use of a medication related to fungal meningitis, which was never used at our facilities. View his interview with WTHR-13 Indianapolis and read the text at
http://www.wthr.com/story/19764263/pharmacy-recalls-steroid-behind-meningitis-outbreak